{"id":399880,"date":"2020-12-15T08:33:15","date_gmt":"2020-12-15T13:33:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=399880"},"modified":"2020-12-15T08:33:15","modified_gmt":"2020-12-15T13:33:15","slug":"cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/","title":{"rendered":"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets<\/b><\/p>\n<p>CONCORD, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCerus Corporation (Nasdaq: CERS) today announced that its distribution partner, Companhia Energ\u00e9tica Integrada (CEI), was awarded a three-year contract with the HemoMinas Foundation (\u201cHemoMinas\u201d) of Brazil for the INTERCEPT Blood System for platelets. HemoMinas provides services and blood products in the state of Minas Gerais, and the Hemocentro of Belo Horizonte \u2013 the largest blood service of HemoMinas \u2013 distributes approximately 25,000 platelet doses to hospitals annually.\n<\/p>\n<p>\n\u201cWe are honored to have been selected by HemoMinas to supply the INTERCEPT Blood System for platelets in the southeastern state of Minas Gerais,\u201d said Hans Vermeij, Cerus\u2019 senior director of commercial operations in Latin America. \u201cHemoMinas\u2019 award is a strong endorsement of the services and products offered by Cerus and CEI, and the importance of pathogen reduced blood components in Brazil,\u201d Vermeij continued.\n<\/p>\n<p>\n\u201cThe introduction of pathogen reduced blood components is an important part of our blood safety strategy in Minas Gerais,\u201d said Dr. Ma\u00edsa Aparecida Ribeiro, medical director at HemoMinas. \u201cINTERCEPT will provide a new foundational strategy for blood safety to protect patients from endemic pathogens, such as Zika virus, Dengue, and Chikungunya virus, and is a timely and forward-looking step as we prepare for the inevitable next emerging pathogen.\u201d\n<\/p>\n<p>\n\u201cCEI is pleased to advance the adoption of the INTERCEPT Blood System in Brazil as we partner with Cerus to establish a new level of safety and availability for blood transfusions,\u201d said Paulo Pacheco, president of CEI. \u201cHemoMinas is highly respected in Brazil and delivers platelet products throughout the entire Minas Gerais state, which has more than 20 million residents,\u201d Pacheco said.\n<\/p>\n<p>\nThe INTERCEPT Blood System for platelets and plasma is the only pathogen reduction system to receive approval from the Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA) for commercial use in Brazil. Over 3.7 million whole blood and apheresis blood components are collected annually in Brazil.\n<\/p>\n<p><b>ABOUT HEMOMINAS<\/b><\/p>\n<p>\nEstablished in 1989, the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) provides services, products, and education in hematology, hemotherapy, cells, tissues. The foundation also ensures unity and direction for state policies related to hematology and hemotherapy, guaranteeing the safe and sufficient supply of quality blood and blood products. HemoMinas distributes approximately 25,000 platelet doses to hospitals annually in the state of Minas Gerais. For more information about Hemominas, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.hemominas.mg.gov.br&amp;esheet=52348520&amp;newsitemid=20201215005284&amp;lan=en-US&amp;anchor=www.hemominas.mg.gov.br&amp;index=1&amp;md5=91d537ab06bf95d74c61c416194c3661\">www.hemominas.mg.gov.br<\/a>.\n<\/p>\n<p><b>ABOUT CEI GROUP<\/b><\/p>\n<p>\nFounded in 1991 by the entrepreneur Paulo Cezar Pacheco, who has more than 45 years of expertise in the health area, the CEI Group portfolio of products boasts of prestigious world trademarks with exclusive rights of distribution across Brazil. Its organizational chart is made up of regional branches strategically placed, its own sales team, and specialized technical assistance.\n<\/p>\n<p>\nThe organization is the market leader in the products that it commercializes. The constant search for innovative products, an integrated sales concept, and high quality of services, with the focus on the needs and satisfaction of the customers, are the strategies that have consolidated the company in the market.\n<\/p>\n<p><b>ABOUT CERUS<\/b><\/p>\n<p>\nCerus Corporation is dedicated solely to safeguarding the world\u2019s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding associated with fibrinogen deficiency, including massive hemorrhage. For more information about Cerus, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cerus.com%2F&amp;esheet=52348520&amp;newsitemid=20201215005284&amp;lan=en-US&amp;anchor=www.cerus.com&amp;index=2&amp;md5=3695e6b3243bfe2bc64b1a4132010f68\">www.cerus.com<\/a> and follow us on LinkedIn.\n<\/p>\n<p>\nINTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201215005284\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201215005284\/en\/<\/a><\/span><\/p>\n<p>\nJessica Hanover \u2013 VP, Corporate Affairs<br \/>\n<br \/>Cerus Corporation<br \/>\n<br \/>925-288-6137\n<\/p>\n<p><b>KEYWORDS:<\/b> California United States South America North America Brazil<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Medical Supplies Medical Devices Health Infectious Diseases Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201215005284\/en\/724993\/3\/cerus_210x60.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets CONCORD, Calif.&#8211;(BUSINESS WIRE)&#8211; Cerus Corporation (Nasdaq: CERS) today announced that its distribution partner, Companhia Energ\u00e9tica Integrada (CEI), was awarded a three-year contract with the HemoMinas Foundation (\u201cHemoMinas\u201d) of Brazil for the INTERCEPT Blood System for platelets. HemoMinas provides services and blood products in the state of Minas Gerais, and the Hemocentro of Belo Horizonte \u2013 the largest blood service of HemoMinas \u2013 distributes approximately 25,000 platelet doses to hospitals annually. \u201cWe are honored to have been selected by HemoMinas to supply the INTERCEPT Blood System for platelets in the southeastern state of Minas &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-399880","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets CONCORD, Calif.&#8211;(BUSINESS WIRE)&#8211; Cerus Corporation (Nasdaq: CERS) today announced that its distribution partner, Companhia Energ\u00e9tica Integrada (CEI), was awarded a three-year contract with the HemoMinas Foundation (\u201cHemoMinas\u201d) of Brazil for the INTERCEPT Blood System for platelets. HemoMinas provides services and blood products in the state of Minas Gerais, and the Hemocentro of Belo Horizonte \u2013 the largest blood service of HemoMinas \u2013 distributes approximately 25,000 platelet doses to hospitals annually. \u201cWe are honored to have been selected by HemoMinas to supply the INTERCEPT Blood System for platelets in the southeastern state of Minas &hellip; Continue reading &quot;Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-15T13:33:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets\",\"datePublished\":\"2020-12-15T13:33:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/\"},\"wordCount\":755,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/\",\"name\":\"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-12-15T13:33:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/","og_locale":"en_US","og_type":"article","og_title":"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets - Market Newsdesk","og_description":"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets CONCORD, Calif.&#8211;(BUSINESS WIRE)&#8211; Cerus Corporation (Nasdaq: CERS) today announced that its distribution partner, Companhia Energ\u00e9tica Integrada (CEI), was awarded a three-year contract with the HemoMinas Foundation (\u201cHemoMinas\u201d) of Brazil for the INTERCEPT Blood System for platelets. HemoMinas provides services and blood products in the state of Minas Gerais, and the Hemocentro of Belo Horizonte \u2013 the largest blood service of HemoMinas \u2013 distributes approximately 25,000 platelet doses to hospitals annually. \u201cWe are honored to have been selected by HemoMinas to supply the INTERCEPT Blood System for platelets in the southeastern state of Minas &hellip; Continue reading \"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-15T13:33:15+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets","datePublished":"2020-12-15T13:33:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/"},"wordCount":755,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/","name":"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-12-15T13:33:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201215005284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cerus-distribution-partner-cei-announces-three-year-tender-award-with-the-minas-gerais-hematology-and-hemotherapy-center-foundation-hemominas-in-brazil-for-the-intercept-blood-system-for\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cerus\u2019 Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/399880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=399880"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/399880\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=399880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=399880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=399880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}